I don’t see the risk coming from the clinic/science, the risk is in management’s execution of Zan overall. I may of the mark here, but with the recent board changes it doesn’t seem that there is a harmonious drive by management to bring Zan to fruition (but this is just my feeling). As many others have said, management really need to be done with board changes, sit down, buckle up and see this thing through!
Ann: Race releases complete cardio-protection data & video, page-86
-
- There are more pages in this discussion • 151 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |